Tower, don't forget there is always pipeline filling at the beginning/launch of a generic that boosts sales as wholesalers/hospitals buy initial stock, ACL have also always said that the payment to Reddy's for development costs is in the single digits.
Add to My Watchlist
What is My Watchlist?